ABVC BioPharma Inc. (ABVC)
Market Closed
16 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
1. 29
+0.03
+2.381%
After Hours
$
+0.26 +20.155% 1. 55
17.24M Market Cap
- P/E Ratio
- Div Yield
426,447 Volume
- Eps
$ 1.26
Previous Close Want to track ABVC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ABVC BioPharma Inc. (ABVC) Statistics
Valuation metrics
Market Cap 17.24M
Enterprise value 19.83M
Trailing P/E (ttm) -3.21
Forward P/E -
PEG ratio 0.14
Price/Sales (ttm) -21.66
Price/Book (mrq) 2.81
Enterprise Value/Revenue -24.92
Enterprise Value/EBITDA -2.16
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 108.84K
Average volume (90 days) 105.85K
Price summary
52-Week low 0.88
52-Week high 5.48
Beta -
50-Day moving average 1.17
200-Day moving average 1.61
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 25 Jul 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 11.84%
Operating margin 11.09%
Operational effectiveness
Return on assets -0.48%
Return on equity -0.92%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -0.03
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.37
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.01
Total debt (mrq) -
Total Debt/Equity (mrq) 0.25
Current ratio (mrq) 0.12%
Book value per share (mrq) 0.5
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
